Category Archives: Publications

23 Oct

Evidence and Values: requirements for public reimbursement of drugs for rare diseases – a case study in oncology

Publications
0 Comments
By
Doubts have been expressed about whether standard methods of health technology assessment are suitable for the evaluation of drugs for rare diseases. Under conditions of rarity, it may be more difficult to conduct large randomized trials in order to gather adequate evidence on efficacy, and the standard methods of economic evaluation may not aserious and/or
19 Oct

We know with accuracy only when we know little

Publications
0 Comments
By
Our title reflects a maxim penned by Goethe. It continues in translation to read ‘With knowledge doubt increases.’1 The papers that appear in this issue stemming from a special symposium held in Banff, Alberta in February 2009, describe our progress toward agreement on the concept of access with evidence development (AED).2-6  Goethe’s reflection summarizes the dilemma. Much
13 Oct

Summary Report – PhRMA International Alliance Development Academic Roundtable

Publications
0 Comments
By
On Wednesday, August 19, 2009, fourteen academics from the U.S., Canada and the UK were joined by select PhRMA staff to participate in a PhRMA International Alliance Development Academic Roundtable. The discussion focused on the issues of biosimilars, also referred to as follow-on biologics (FOBs), health technology assessment (HTA), and intellectual property protection. Summary Report
24 Apr

History, Evidence and Reason: A review of proposals for and innovative sources of funding to stimulate R&D

Publications
0 Comments
By
UN Public Consultation on new and innovative sources of funding to stimulate R&D (April 2009) Dr. D. Wayne Taylor, Ph.D., F.CIM A/Executive Director, The Cameron Institute The Cameron Institute welcomes this opportunity to participate in the United Nation’s public consultation on new and innovative sources of funding to stimulate research and development, with specific reference
08 Apr

Quantifying cost avoidance possibilities by investing in the minimally-invasive mid-urethral sling surgical treatment of stress urinary incontinence

Publications
0 Comments
By
Journal of Medical and Biological Sciences – Volume 3, Issue 1, 2009 D. Wayne Taylor, Director, Health Leadership Institute, McMaster University Elisabeth Fowler, Vice-President, Ward Health Strategies Urinary incontinence is one of the most prevalent, untreated chronic conditions for individuals living in Canada. The impact of incontinence on an individual’s quality of life is significant as
07 Apr

Patient-Centred Care: Does Asthma Pass The Test?

Publications
0 Comments
By
Journal of Medical and Biological Sciences – Volume 2, Issue 1, 2008 D. Wayne Taylor, Director, Health Leadership Institute, McMaster University Elisabeth Fowler, Vice-President, Ward Health Strategies This study examined the degree to which the five principles embedded in IAPO’s Declaration on Patient-Centred Healthcare are being advocated and utilized in the asthma patient-provider relationship in
10 Dec

Measuring the biobased economy: A Canadian perspective

Publications
0 Comments
By
Industrial Biotechnology, Winter 2008 (Vol. 4, No. 4) William Pellerin and D. Wayne Taylor The concept of the biobased economy goes beyond the traditional definition of biotechnology. Understanding the biobased economy facilitates the right financial, policy, and regulatory frameworks that enable the integration of biotechnology into traditional economic sectors while also revitalizing these sectors. Comparing